1 e statin therapy may reduce lipid content in obstructive lesions.

2  repair for infants with multiple left heart obstructive lesions.

3  repair for infants with multiple left heart obstructive lesions.

4 applicable to patients with other left heart obstructive lesions.

5 nted by patients with cyanotic or left heart obstructive lesions.

6 enital or acquired left-heart inflow/outflow obstructive lesions and congenital cardiomyopathies have

7 is unexpected finding, associated left heart obstructive lesions and pulmonary and left ventricular e

8 otruncal, and left ventricular outflow tract obstructive lesions are underway.

9 lesions and may be considered as a boost for obstructive lesions before chemotherapy and external bea

10 /- 1% for isografts, P < 0.05) with sites of obstructive lesion formation coinciding with areas of CD

11 ral arteries (MV-D)--and 2 fetal constructs--obstructive lesions (FV-O) and bleeding/vessel integrity

12 que (calcified, noncalcified, or mixed), and obstructive lesions (&gt;50% luminal narrowing) were relate

13 al shunting was found with severe left heart obstructive lesions, including 19 with hypoplastic left

14 s shunting was found with severe right heart obstructive lesions, including nine fetuses with pulmona

15 ped into 5 constructs: 3 maternal constructs-obstructive lesions (MV-O), bleeding/vessel integrity (M

16          Primary nitinol stent placement for obstructive lesions of the popliteal artery achieves sup

17 ilable evaluating endovascular treatment for obstructive lesions of the popliteal artery.

18 t of intravascular stents for focal vascular obstructive lesions reverses allograft dysfunction.

19                             Proximity of the obstructive lesion to the AoV and severe obstruction det

20 nsitivity and specificity, respectively, for obstructive lesions were 100% and 100% for the aorta, 10